ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024

Core Viewpoint - ImmuCell Corporation is set to report its unaudited financial results for Q3 2024 on November 13, 2024, and will host a conference call the following day to discuss these results [1][2][3]. Financial Reporting - The company anticipates no changes to the preliminary sales results for Q3 2024, which were previously disclosed on October 8, 2024 [3]. - The Quarterly Report on Form 10-Q will be filed after market close on November 13, 2024 [3]. Conference Call Details - A conference call to review the unaudited financial results will take place on November 14, 2024, at 9:00 AM ET, accessible via specific dialing options [2]. - A teleconference replay will be available until November 21, 2024, with a designated access code [2]. Corporate Presentation - Investors are encouraged to review the updated Corporate Presentation slide deck available on the company's website, which will be updated after the financial results are released [4]. Company Overview - ImmuCell Corporation focuses on developing products that enhance the health and productivity of dairy and beef cattle, including First Defense® for newborn calves and Re-Tain®, a treatment for subclinical mastitis [5].